iShares Russell 2000 ETF Newsroom

Lantheus Holdings Analyst Ratings

Benzinga08:54 ET

Jefferies Reaffirms Their Buy Rating on Lantheus (LNTH)

TipRanks08:17 ET

Buy Rating Affirmed for Lantheus Holdings With Enhanced Revenue Projections and Strategic Expansion

TipRanks12:12 ET

Barclays Adjusts Price Target on Fluor to $45 From $39, Maintains Equalweight Rating

MT NewswiresJul 18 11:27 ET

Fluor Analyst Ratings

BenzingaJul 18 11:07 ET

Barclays Sticks to Its Hold Rating for Fluor (FLR)

TipRanksJul 18 04:23 ET

Fluor Analyst Ratings

BenzingaJul 17 05:37 ET

Keybanc Upgrades Fluor to Overweight, Announces $57 Price Target

BenzingaJul 17 05:37 ET

Sprouts Farmers Market Analyst Ratings

BenzingaJul 16 11:28 ET

Insmed Analyst Ratings

BenzingaJul 12 13:02 ET

Barclays Keeps Their Buy Rating on Insmed (INSM)

TipRanksJul 12 04:19 ET

Analyst Ratings For Abercrombie & Fitch

BenzingaJul 11 09:03 ET

Abercrombie & Fitch Analyst Ratings

BenzingaJul 11 07:48 ET

Lantheus Holdings Analyst Ratings

BenzingaJul 11 07:24 ET

Analysts Conflicted on These Healthcare Names: Lantheus (LNTH) and Catalent (CTLT)

TipRanksJul 11 06:42 ET

Truist Securities Adjusts Price Target on Lantheus Holdings to $141 From $96, Maintains Buy Rating

MT NewswiresJul 11 05:19 ET

Lantheus Buy Rating Affirmed Amid Favorable CMS Changes and Strong Market Position

TipRanksJul 10 14:59 ET

Goldman Sachs Raises Price Target on Insmed to $102 From $74, Maintains Buy Rating

MT NewswiresJul 10 11:52 ET

Goldman Sachs Maintains Buy on Insmed, Raises Price Target to $102

BenzingaJul 10 11:27 ET

Goldman Sachs Adjusts Price Target on Sprouts Farmers Market to $89 From $78, Maintains Buy Rating

MT NewswiresJul 10 10:34 ET